Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Acute Coronary Syndrome

• Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial
• Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
• The Effect of Colchicine on Inflammation in ACS Patients
• Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
• De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS
• Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
• Platelet Sub-study of the Neomindset Trial
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
• Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty
• Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
• Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
• NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
• To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
• Study to Investigate CSL112 in Subjects With ACS
• Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
• Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
• Polypill in Acute Coronary Syndrome
• Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence
• Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome
• Evolocumab Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
• Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics
• Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
• "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
• Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
• Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin
• Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study
• COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
• Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia
• Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
• Pharmacokinetic/Pharmacodynamic Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers
• Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
• Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
• PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population
• Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)
• Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
• 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
• Rivaroxaban in Left Ventricular Thrombus
• Mono Antiplatelet and Colchicine Therapy
• MonotherApy of Low-does TicagrElor After Percutaneous Coronary Intervention
• A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
• Colchine for the Stability of Coronary Plaque in Acute Coronary Syndrome(COLOCT)
• Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
• Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008
• Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
• Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
• The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
• MT1002 Phase II Study in ACS Patients With PCI
• Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome
• Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
• Role of Alprazolam in the Management of Acute Coronary Syndrome
• Adrenaline for the Treatment of No-Reflow in Normotensive Patients
• Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
• Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
• VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
• Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
• Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment
• ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
• PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
• Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome
• Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients
• ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
• Oral Colchicine in Argentina to Prevent Restenosis
• Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction
• Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome
• PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial
• Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
• Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
• A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients
• A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients
• Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
• A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
• Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY
• Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
• Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
• OPTImal Management of Antithrombotic Agents: OPTIMA-5
• Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome
• Evolocumab in Patients With Acute MI
• LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
• Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
• Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
• Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
• DUAL Antithrombotic Therapy in Patients With AF and ACS
• Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
• Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
• Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
• The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin
• Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial
• Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS
• Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
• Allopurinol in Acute Coronary Syndrome
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
• Inflammation Reduction by TREhalose AdminisTration
• Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)
• The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
• Reduce Bolus Injection of Bivalirudin
• Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• Evolocumab in Acute Coronary Syndrome
• ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
• A Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary Syndrome
• Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
• Efficacy and Safety of Low-dose Ticagrelor
• Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
• TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
• The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention
• EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
• Add-on Cangrelor in STEMI-triggered Cardiac Arrest
• Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
• Smoking Cessation After Acute Coronary Syndrome
• Milrinone Versus Dobutamine in Critically Ill Patients
• Impact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide
• Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
• Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
• Polyprenols (Ropren) in Acute Coronary Syndrome
• Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
• Low Dose Interleukin-2 in Patients With Stable Ischaemic Heart Disease and Acute Coronary Syndromes
• Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT
• Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity
• Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach.
• Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
• Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
• Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
• The Effect on EPCs by Statin Loading in "All Comers" With an ACS
• Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
• Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
• Acute Coronary Syndrome Sri Lanka Audit Project
• LEADERS FREE II: BioFreedom™ Pivotal Study
• High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
• Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome
• The Effect of DPP4 Inhibitor on Vasclular Healing
• Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI
• WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)
• The Effect of IV Cangrelor and Oral Ticagrelor Study
• Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients
• High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay
• MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
• Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
• What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
• Patent Versus Generic Clopidogrel in Acute Coronary Syndrome
• Comparing Ticagrelor Versus Clopidogrel on Microcirculation
• Colchicine in Percutaneous Coronary Intervention
• Cocktail Injection Improves Outcomes of FFR Guided PCI
• COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
• Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
• Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS
• Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA Registry
• Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
• Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
• Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
• The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
• CER-001 Atherosclerosis Regression ACS Trial
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
• Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
• The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome
• Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
• Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients
• Dose-escalation, Repeated and Single Oral Dosing Study
• Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the H
• Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study
• The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
• Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
• Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
• Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
• Rosuvastatin Effect on Telomere-telomerase System in ACS
• A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
• Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
• Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
• Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)
• Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes
• EndoTic - Endothelium and Ticagrelor
• Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis
• Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
• Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
• REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.
• Enoxamed Study in the Treatment of Acute Coronary Syndromes
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
• Intensive Arterial Pressure Control in Acute Coronary Syndrome
• The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man
• Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
• Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS
• Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity
• Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
• Drug Interaction Statin
• Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes
• Triple vs. Dual Therapy
• LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
• Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS
• Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)
• Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?
• Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
• Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
• Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
• A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
• Paradigm Shift in the Treatment of Patients With ACS
• Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
• Safety Study of APD-791 With Aspirin and/or Clopidogrel
• Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .
• Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
• "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-
• Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
• Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
• Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
• Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes
• Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
• Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary
• Post Acute Coronary Event Smoking Study
• Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI
• Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
• Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
• Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
• Dexmedetomidine for Reversal of Cocaine's Effects on the Heart
• Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients
• Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
• Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study
• Colchicine for Acute Coronary Syndromes
• Renal Denervation in Patients After Acute Coronary Syndrome
• Hormones Inflammation and Thrombosis
• Brilinta DaYu Study
• Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)
• A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS
• Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coro
• The ACS Ethnicity Platelet Function Study
• Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
• Efficacy and Safety Study of Ticagrelor
• Antithrombotic Triple Therapy in Humans
• Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor
• BLeeding Events and Maintenance DoSe of PraSugrel
• An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
• Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
• The Elderly ACS II Trial
• Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
• Ranolazine Cardioprotection in PCI
• A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin
• Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
• Tailored Antiplatelet Therapy Following PCI
• Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)
• Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)
• Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
• VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel
• Citalopram for Sx/Util in Acute Coronary Syndrome Patients
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
• Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
• Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects
• Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
• Phase I Study of GW856553 (Losmapimod)
• Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
• Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study
• Antithrombotic Effects of Ticagrelor Versus Clopidogrel
• PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
• Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome
• Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
• Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention
• Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients
• Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy
• Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel
• Controlled Level EVERolimus in Acute Coronary Syndromes
• Study of LC23-1306 in Healthy Male Subjects
• Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
• Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
• Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents
• Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
• Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin Loading
• Customized Choice of Oral P2Y12 Receptor Blocker
• Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial
• Allopurinol in Acute Coronary Syndrome
• Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
• Statins Evaluation in Coronary Procedures and Revascularization Trial
• Comparative Pharmacokinetics of YH14659
• Fondaparinux EU-RMP (Adherence)
• Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome
• Microcirculation In Acute Coronary Syndromes
• Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
• The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel
• Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
• A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)
• Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
• Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
• A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
• Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
• Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
• Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
• Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
• Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
• Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery
• Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease
• Statin Contrast Induced Nephropathy Prevention
• Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery
• Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
• A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
• Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
• Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
• VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
• Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI)
• Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
• Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
• Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
• Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
• Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
• Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
• European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
• The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome
• Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
• Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
• Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
• A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
• Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
• Comparison of Depression Interventions After Acute Coronary Syndrome
• A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
• Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I
• PGD2 Formation in Vascular Injury
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
• Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome
• Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes
• The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome
• Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
• Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
• Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
• A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
• Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time
• Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice
• Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
• A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation
• BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)
• Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
• Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome
• A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients
• Phase III Acute Coronary Syndrome
• A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
• Acarbose Cardiovascular Evaluation Trial
• Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy
• Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
• Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome
• An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
• Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
• Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)
• Tirofiban and Enoxaparin in High Risk Coronary Intervention
• Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
• Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
• Maintenance of Platelet Inhibition With Cangrelor
• Platelet Hyperreactivity to Aspirin and Stroke
• Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque
• Targeting Inflammation in Acute Coronary Syndrome Using Colchicine
• FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
• Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
• Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
• China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome
• Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects
• Pain Relief of Metoprolol Versus Metoprolol Plus Morphine in Acute Chest Pain
• Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction
• Shanghai Registry of Acute Coronary Events
• Telmisartan Versus Ramipril After Acute Coronary Syndrome
• Change in Plaque Characteristics With Atorvastatin
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
• Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial
• Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)
• Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
• Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
• Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
• A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
• GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
• Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction
• RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome
• A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome
• Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
• Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event
• Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
• Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
• Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?
• Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization
• Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
• Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
• Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
• Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome
• Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
• Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
• Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
• Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation
• Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation
• Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
• The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
• Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
• Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
• Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina
• Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
• Effects of Atorvastatin on Myonecrosis
• Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients
• Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation
• A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)
• Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
• Safety Study of Apixaban in Recent Acute Coronary Syndrome
• A Clinical Trial to Demonstrate the Efficacy of Cangrelor
• Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
• ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
• A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.
• Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
• Serp-1 for the Treatment of Acute Coronary Syndrome
• Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
• Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL
• LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
• A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
• IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)
• Fluvastatin in the Therapy of Acute Coronary Syndrome
• DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
• Michelangelo - Oasis 5
• Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32
• Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
• A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
• Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
• EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
• Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)
• SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes